Atif J. Khan, MD
Director, Proton Beam Center
Rutgers Cancer Institute of New Jersey
Phone: (732) 253-3939
Assistant: Tita Yeager
Research Program Alignments
- Clinical Investigations Program
Membership Type: Associate - CCSG
- Partial Breast Radiation
- Glutamate Receptor
Khan AJ, Vicini FA, Brown S, Haffty BG, Kearney T, Dale R, Lyden M, and Arthur D. (2012) Dosimetric Feasibility and Acute Toxicity in a Prospective Trial of Ultra-short Course Accelerated Partial Breast Irradiation (APBI) using a Multi-Lumen Balloon Brachytherapy Device. Ann Surg Oncol. In press.
Khan AJ, Parikh RR, Neboori HJ, Goyal S, Haffty BG, and Moran MS. (2012) The Relative Benefits of Tamoxifen in Older Women with T1 Early-Stage Breast Cancer Treated with Breast-Conserving Surgery and Radiation Therapy. The Breast J. In press.
Khan AJ, Vicini FA, Keisch M, Goyal S, Beitsch PD, Haffty BG. (2012) Six- Year Analysis of Treatment Related Toxicities in Patients Treated With Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol. 19(5):1477-83.
Kathpal M, Mayer T, Rhodes R, Danish S, Khan AJ. (2012) Importance of initial aggressive treatment for pineal parenchymal tumor of intermediate differentiation: A case report and review of literature. Pract Rad Onc. May 7 Epub.
Khan AJ, Vicini FA, Beitsch P, Goyal S, Kuerer H, Kiesch M, Quiet C, Zannis V, Keleher A, Snider H, Gittleman M, Whitworth P, Fine R, Lyden M, and Haffty BG. (2012) Local Control, Toxicity, and Cosmesis in Women over 70 Enrolled on the American Society of Breast Surgeons MammoSite RTS Registry Trial. Int J Radiat Oncol Biol Phys. Feb 21 Epub.
Vicini FA, Keisch M, Goyal S, Khan AJ, Beitsch PD, Lyden M, Shah C, Haffty BG. Factors Associated with Optimal Long-Term Cosmetic Results in Patients Treated with Accelerated Partial Breast Irradiation (APBI) Using Balloon Based Brachytherapy. (2012) Int J Radiat Oncol Biol Phys. 83(2):512-8.
Khan AJ, Wall B, Ahlawat S, Green C, Schiff D, Mehnert JM, Goydos JS, Chen S, Haffty BG. (2011). Riluzole Enhances Ionizing Radiation-induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor In Vitro and In Vivo. Clinical Cancer Research, 17(7), 1807-14.
Daroui P, Gabel M, Khan AJ, Haffty BG, Goyal S. (2011). Utilization of Breast Conserving Therapy in Stage 0, I, II Breast Cancer Patients in New Jersey: An American College of Surgeons National Cancer Data Base (NCDB) Analysis. Am J Clin Oncol. Feb 15 (Epub).
Taunk NK, Haffty BG, Chen S, Khan AJ, Nelson C, Pierce D, Goyal S. (2011). Comparison of Radiation-Induced Fatigue Using 3 Radiotherapeutic Methods in Early Stage Breast Cancer Radiotherapy. Cancer. March 1 (Epub).
Goyal S, Rao MS, Khan A, Huzzy L, Green C, Haffty BG. (2011). Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with bevacizumab. Int J Radiat Oncol Biol Phys 79 (2), 408-13.
Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler NJ, Abrams RA, Bonomi P, Liptay M, Faber LP. (2011). Weight Gain in Advanced Non-Small Cell Lung Cancer Patients During Treatment with Split-Course Concurrent Chemoradiotherapy is Associated with Superior Survival. Int J Radiat Oncol Biol Phys. 81(4):985-91.
Yue NJ, Goyal S, Zhou J, Khan AJ, Haffty BG. (2011) Intrafractional Target Motions and Uncertainties of Treatment Setup Reference Systems in Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys. 79(5):1549-56.
Rao M, Khan AJ, Moran MS, Hirshfield KM, Ganesan S, Haffty BG, Goyal S. (2011). Clinicopathologic Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer. J Immigr Minor Health. 13 (1); 42-28.
Improvement in interobserver accuracy in delineation of the lumpectomy cavity using fiducial markers. Shaikh T, Chen T, Khan A, Yue NJ, Kearney T, Cohler A, Haffty BG, Goyal S. (2010) Int J Radiat Oncol Biol Phys. 78(4):1127-34.
Mutyala S, Stewart AJ, Khan AJ, Cormack RA, O'Farrell D, Sugarbaker D, Devlin PM. (2010). Permanent Iodine-125 Interstitial Planar Seed Brachytherapy for Close or Positive Margins for Thoracic Malignancies. Int J Radiat Oncol Biol Phys, 76 (4), 1114-1120.